China’s Ministry of Public Security said four high-level executives from GlaxoSmithKline were detained on bribery charges.
Related Articles Read More >
Exploring Merck’s key arguments in its constitutional challenge against the Inflation Reduction Act
The need for a data-driven culture in life sciences: What you don’t know can hurt you
